Related Experiment Video
Updated: May 22, 2026

Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas
1Department of Neurosurgery, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
Abstract:
Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) expression is often silenced in many types of human tumors. However, the relationship between RIZ1 expression and malignant meningiomas remains unclear. Here we have found for the first time that the expression of RIZ1 genes are associated with meningiomas progression through extensive analyses of Affymetrix GeneChip microarray data. Further validation methods for gene expression included quantitative PCR (qPCR), western blot and immunohistochemistry analysis, and these methods confirmed that RIZ1 is significantly downregulated in malignant meningioma tissues, as compared with benign meningiomas. In addition, malignant meningioma cells were stably transfected with ectogenic RIZ1 using Lentivirus-mediated transfection, and the transfections were followed by an in vitro 5-bromo-2-deoxyuridin incorporation assay, colony formation assay, cell cycle analysis, invasive analysis, apoptotic assay and western blot analysis. Our results demonstrate that the forced expression of RIZ1 in a malignant meningioma cell line inhibited cellular proliferation and arrested the cells in the G2/M phase of the cell cycle. We also confirmed that overexpression of RIZ1 may induce apoptosis of malignant meningioma cells. Furthermore, RIZ1 overexpression in malignant meningioma cells was associated with the downregulation of c-myc expression. These results from our study indicate that RIZ1 expression is significantly downregulated as the formation of meningiomas progressed, and suggest that RIZ1 may represent a promising candidate tumor suppressor gene that contributes to malignant meningiomas.
Insights
Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) is downregulated in malignant meningiomas. Restoring RIZ1 expression inhibits tumor cell growth, suggesting RIZ1 is a potential tumor suppressor for meningiomas.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) is frequently silenced in human cancers.
- The role of RIZ1 in meningioma progression, particularly malignant meningiomas, is not well understood.
Purpose of the Study:
- To investigate the association between RIZ1 gene expression and the progression of meningiomas.
- To determine the functional role of RIZ1 in malignant meningioma cells.
Main Methods:
- Analysis of Affymetrix GeneChip microarray data.
- Validation using quantitative PCR (qPCR), western blot, and immunohistochemistry.
- In vitro functional assays including proliferation, cell cycle, invasion, and apoptosis assays after RIZ1 overexpression via lentivirus transfection.
Main Results:
- RIZ1 expression is significantly downregulated in malignant meningiomas compared to benign ones.
- Forced RIZ1 expression in malignant meningioma cells inhibited proliferation and induced G2/M cell cycle arrest.
- RIZ1 overexpression promoted apoptosis and was associated with decreased c-myc expression.
Conclusions:
- RIZ1 expression decreases with meningioma progression.
- RIZ1 functions as a tumor suppressor in malignant meningiomas.
- RIZ1 may be a potential therapeutic target for meningiomas.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
